DrugPatentWatch Database Preview

Anchen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?

ANCHEN PHARMS has twenty-five approved drugs.

There are two tentative approvals on ANCHEN PHARMS drugs.

Summary for Anchen Pharms

US Patents:	0
Tradenames:	21
Ingredients:	21
NDAs:	25

Drugs and US Patents for Anchen Pharms

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anchen Pharms	QUETIAPINE FUMARATE	quetiapine fumarate	TABLET, EXTENDED RELEASE;ORAL	090757-002	Dec 1, 2017	AB	RX	No	No
Anchen Pharms	VENLAFAXINE HYDROCHLORIDE	venlafaxine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	078087-002	Mar 16, 2012		DISCN	No	No
Anchen Pharms	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	091360-001	Oct 4, 2011	AB	RX	No	No
Anchen Pharms	FLUVOXAMINE MALEATE	fluvoxamine maleate	CAPSULE, EXTENDED RELEASE;ORAL	091476-001	Mar 13, 2013	AB	RX	No	No
Anchen Pharms	TRAMADOL HYDROCHLORIDE	tramadol hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200491-002	Jun 27, 2012	AB2	RX	No	No
Anchen Pharms	TRAMADOL HYDROCHLORIDE	tramadol hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200491-003	Jun 27, 2012	AB2	RX	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Anchen Pharms